ROS1 rearrangements are uncommon in biliary tract cancers

Biliary tract cancers (BTCs) are a pool of diseases with poor prognosis and there is no orphan drug available. Currently, no molecular targets have been tested as druggable oncogenic drivers. C-ros oncogene 1 (ROS1) rearrangements have been previously described in various tumors, including BTCs; how...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncol Lett
Päätekijät: Mazzoni, Francesca, Petreni, Paolo, Vasile, Enrico, Panebianco, Michele, Casadei-Gardini, Andrea, Negri, Francesca, Lunghi, Alice, Pillozzi, Serena, Vivaldi, Caterina, Gervasi, Erika, Frassineti, Giovanni Luca, Messerini, Luca, Jocollé, Genny, Bisagni, Alessandra, Antonuzzo, Lorenzo, Rossi, Giulio
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: D.A. Spandidos 2020
Aiheet:
Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7590438/
https://ncbi.nlm.nih.gov/pubmed/33133252
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2020.12179
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia